Oncolytics Biotech INC F-1 registration statements

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous registration statements.

Oncolytics Biotech Inc. files post-effective amendments to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech Inc. has filed post-effective amendments to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. is filing post-effective amendments to deregister unsold securities from multiple previous registration statements.

Oncolytics Biotech files post-effective amendments to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech files post-effective amendments to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. files a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior F-10 registration statements.

Oncolytics Biotech Inc. is filing a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. files a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements, updating the effectiveness date for remaining registrations.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior F-10 registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to multiple registration statements to revise the effectiveness date for the deregistration of unsold securities.

Oncolytics Biotech Inc. has filed a post-effective amendment to its F-10 registration statements to revise the effectiveness date for the deregistration of unsold securities.

Oncolytics Biotech files post-effective amendment to withdraw unsold securities from multiple prior registration statements, revising effectiveness date for remaining registrations.

Oncolytics Biotech Inc. filed a post-effective amendment to deregister unsold portions of securities from multiple previous shelf registration statements.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements for unsold securities.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw unsold portions of securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements for unsold securities.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements, deregistering unsold portions of various securities.

Oncolytics Biotech Inc. has filed post-effective amendments to deregister unsold portions of securities from multiple previous registration statements.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements, deregistering unsold securities.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements, deregistering unsold portions of various securities.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements for unsold securities.

Oncolytics Biotech Inc. has filed a short form base shelf prospectus to offer up to C$150 million in common shares, subscription receipts, warrants, and units over a 25-month period.